Quantum Pharma Share News (QP.)

Quantum Pharma conditionally raises £15m in accelerated bookbuild

(ShareCast News) - Quantum Pharma confirms its accelerated bookbuild to raise up to £15m has closed successfully, subject to the passing of certain resolutions by shareholders at the company's annual meeting. The company, which noted that it continued to trade in line, believed net proceeds would re

Quantum Pharma Raises GBP15 Million To Pay Down Debt (ALLISS)

Quantum Pharma's shares plummet as it expects to perform below expectations in H2

(ShareCast News) - Shares in AIM-listed drug manufacturer Quantum Pharma plunged nearly 50% on Tuesday morning as it said it expects the performance in the second half of the year to be "materially below market expectations" although it anticipates "strong" growth. Chief financial officer and acting

Quantum Pharma looks to meet FY market expectations

(ShareCast News) - Quantum Pharma has made good progress during its first half, in line with management views, and anticipates meeting market expectations for the full year. "As previously indicated, the group's performance for the year is second-half weighted and will be dependent on the level of s

Quantum Pharma's Colonis Launches Peptic Ulcer Treatment

Quantum Pharma completes Mucodis range with vaginal cream

(ShareCast News) - Niche pharmaceutical developer Quantum Pharma announced on Friday that its subsidiary Colonis has launched Mucodis vaginal cream. The AIM-traded company said the cream is part of the Mucodis range of in-licensed patented medical devices, which focus on treating some of the side ef

Quantum Pharma launches Mucodis Rectal Gel

(ShareCast News) - Quantum Pharma said Colonis has launched its Mucodis Rectal Gel for preventing and treating rectal mucositis, a common side effect of chemotherapy and radiotherapy in cancer patients. Mucositis is a condition characterised by pain and inflammation of the body's mucous membranes wh

Quantum Pharma Launches Mucodies Rectal Gel Product

Quantum Pharma CEO Scaife steps down, trading in line

(ShareCast News) - Quantum Pharma chief executive Andrew Scaife has stepped down after seven years but is leaving the company with current trading running in line with management expectations. Scaife has decided to leave the Newcastle-upon-Tyne company due to family reasons but has agreed to stay un

Quantum Pharma CEO Resigns As First-Half Trading Meets Expectations

Quantum Pharma launches third product from its Mucodis range of treatments

(ShareCast News) - Quantum Pharma launched the third product of its Mucodis range for the treatment of some of the side effects suffered by patients undergoing cancer treatment. Mucodis dermal spray, which reached markets on Monday, was targetted at treating radiation-induced dermatitis, a condition

Quantum Pharma's Colonis Launches Mucodis Dermal Spray

UK Shareholder Meetings Calendar - Next 7 Days

Quantum Pharma Set To Commercialise Biodose Connect Device

Quantum Pharma Profit Surges And Dividend Hiked After Strong Year